During mitosis, a select pool of MEK1 and p42/p44 MAPK becomes activated at the kinetochores and spindle poles, without substantial activation of the bulk of the cytoplasmic p42/p44 MAPK. Recently, we set out to identify the MAP kinase kinase kinase (MAPKKK) responsible for this mitotic activation, using cyclin-treated Xenopus egg extracts as a model system, and presented evidence that Mos was the relevant MAPKKK . However, a second MAPKKK distinct from Mos was readily detectable as well. Here, we partially purify this second MAPKKK and identify it as B-Raf. No changes in the activity of B-Raf were detectable during progesteroneinduced oocyte maturation, after egg fertilization, or during the early embryonic cell cycle, arguing against a role for B-Raf in the mitotic activation of MEK1 and p42 MAPK. Ras proteins can bring about activation of MEK1 and p42 MAPK in extracts, and Ras may contribute to signaling from the classical progesterone receptor during oocyte maturation and from receptor tyrosine kinases during early embryogenesis. We found that both B-Raf and C-Raf, but not Mos, are required for Ras-induced MEK1 and p42 MAPK activation. These data indicate that two upstream stimuli, active Ras and active Cdc2, utilize different MAPKKKs to activate MEK1 and p42 MAPK.
Introduction
ERK1 and ERK2 (extracellular signal-regulated kinases 1 and 2) are probably the best studied and best understood of the mitogen-activated protein kinases (MAPKs). ERK1 and ERK2 respond to diverse stimuli, and play important roles in cell proliferation, differentiation, and survival (Ferrell, 1996a; Robinson and Cobb, 1997; Lewis et al., 1998; Ferrell, 1999b; Widmann et al., 1999) . Their immediate upstream activators are the kinases MEK1 and MEK2 (for MAPK kinase or ERK kinase), which phosphorylate ERK1 and ERK2 at a threonine and a tyrosine residue in the kinase domain activation loop. MEK1 and MEK2, in turn, are activated by phosphorylation of one or two serine sites in their activation loops (Alessi et al., 1994) . Three families of MEK1/2-activating MAP kinase kinase kinases (MAPKKKs) have now been identified: the Raf family, consisting of the A-Raf, B-Raf, and Raf-1 or C-Raf proteins; the Ste11/Byr1-related MEKK family, consisting of MEKK1, MEKK2, MEKK3, and MEKK4; and the Mos oncoprotein. The diversity of the MAPKKKs may allow MEK1/2 and ERK1/2 proteins to plug into different upstream receptors and regulators.
The serine/threonine protein kinases of the Raf family have long been implicated in relaying mitogenic signals to MAPKs (Morrison and Cutler, 1997; Kolch, 2000; Murakami and Morrison, 2001; Chong et al., 2003) . For example, the gene for the best studied Raf protein, C-Raf, was initially identified as the cellular homolog of the retroviral oncogenes, v-raf and v-mil, underscoring the potential of C-Raf to be a mitogenic regulator (Jansen et al., 1984) . More recently, B-Raf has been shown to be mutated in more than 60% of melanomas and a substantial percentage of many other human cancers (Davies et al., 2002; Pollock and Meltzer, 2002; Rajagopalan et al., 2002; Chong et al., 2003; Pollock et al., 2003; Wan et al., 2004) , suggesting that this Raf family member is of particular importance in human disease. All three of the Raf proteins can be activated by Ras proteins, and all can phosphorylate and activate MEK1; C-Raf can activate MEK2 as well (Pritchard et al., 1995; Wu et al., 1996; Marais et al., 1997) . The three Raf proteins are expressed in overlapping but distinct patterns, with A-Raf exhibiting the most restricted distribution. Likewise, studies of knockout mice suggest that there are both overlapping and isoform-specific functions of the three Raf proteins, with the B-Raf and C-Raf single knockouts producing embryonic lethality (showing that the Raf proteins are probably not completely redundant functionally), but with cells from the single knockouts showing relatively normal p42 MAPK responses (suggesting some redundancy between the Rafs or between Rafs and other MAPKKKs) (Murakami and Morrison, 2001) .
We have been studying the regulation of the MEK1 and ERK2 (or p42 MAPK) protein kinases in Xenopus oocytes, eggs, and egg extracts. The best characterized initiator of oocyte maturation is progesterone, and it brings about the activation of MEK1 and p42 MAPK through the intermediacy of the Mos MAPKKK (Ferrell, 1999b; Nebreda and Ferby, 2000; Maller, 2003) . There may be other routes from progesterone to p42 MAPK activation as well; for example, progesterone binding to the classical progesterone receptor can relay nontranscriptional signals via the Src protein kinases, which may then couple to MEK1 and p42 MAPK via C-Raf (Boonyaratanakornkit et al., 2001 ). In addition, recent work has shown that in mouse ovarian follicles, gonadotropin signaling results in the production of a succession of EGF receptor ligands, which may also couple to MEK1 and p42 MAPK via C-Raf (Park et al., 2004) . These various triggering stimuli culminate in the all-or-none activation of p42 MAPK and Cdc2, which reinforce each other's activation through positive feedback. After eggs are fertilized, the positive feedback loop is broken, the metaphase arrest is released, and p42 MAPK is inactivated (Ferrell, 1999a, b) . Thereafter, during embryogenesis a small proportion of the cell's p42 MAPK becomes transiently activated when the embryo enters mitosis (Guadagno and Ferrell, 1998; Yue and Ferrell, 2004) . Mitotic activation of ERK1/2 is also seen in several mammalian cell lines, and may play a role in regulating the timing of anaphase onset and mitotic exit Zecevic et al., 1998) .
Recently, we attempted to identify the MAPKKK responsible for activating MEK1 and p42 MAPK in interphase Xenopus egg extracts treated with a nondestructable cyclin, D90-cyclin B, a system that produces a permanent mitotic state and so provides a good source material for kinases active in M-phase (Yue and Ferrell, 2004) . We presented several lines of evidence that Mos was the responsible MAPKKK. First, we found that although much of the egg's Mos is degraded after fertilization, enough Mos persists in early embryos and interphase egg extracts to be functionally significant. Second, we found that Mos is active in D90-cyclin B-treated extracts, and is inactive in mock-treated interphase extracts, as would be expected of a MAPKKK responsible for the mitotic activation of MEK1 and p42 MAPK. Third, we found that Mos copurified with a D90-cyclin B-stimulated MAPKKK activity over several column steps. Finally, we found that immunodepleting Mos from Xenopus egg extracts renders the extracts unable to activate p42 MAPK in response to D90-cyclin B, and that adding back recombinant Mos partially restores p42 MAPK activation (Yue and Ferrell, 2004) . Together these results argue that the Mos protein is largely responsible for D90-cyclin B-induced activation of p42 MAPK.
However, we also noted that Mos was not the only MAPKKK activity present in D90-cyclin B-treated extracts. A second MAPKKK, which was comparable in activity to Mos in D90-cyclin B-treated extracts, and was the main MAPKKK activity present in interphase extracts, was also detectable. Here, we set out to identify this second MAPKKK, to test the hypothesis that it collaborates with Mos in the mitotic activation of p42 MAPK, and to identify under what circumstances its activity is regulated. We have identified this MAPKKK as B-Raf, and have cloned and sequenced a Xenopus B-Raf cDNA. Furthermore, we have shown that B-Raf is neither activated by D90-cyclin B/Cdc2 nor required for D90-cyclin B/Cdc2-induced p42 MAPK activation; B-Raf appears not to be involved in the mitotic activation of MEK1 and p42 MAPK. However, we have also shown that B-Raf and C-Raf together are responsible for the Ras-induced activation of MEK1 and p42 MAPK in extracts. B-Raf and C-Raf may therefore function together as key intermediaries in tyrosine kinase-stimulated MAPK activation in Xenopus oocytes, eggs, and embryos.
Results

Activation of the p42 MAPK cascade by Cdc2-cyclin B in
Xenopus egg extracts We prepared cycloheximide-treated interphase egg extracts, and drove them into M-phase by adding nondegradable D90-cyclin B. In agreement with previous studies (Roy et al., 1991; VanRenterghem et al., 1993; Fukuda et al., 1994; Minshull et al., 1994; Guadagno and Ferrell, 1998; Yue and Ferrell, 2004) , this resulted in high levels of MEK1 and p42 MAPK activity ( Figure 1a) . We fractionated these extracts by chromatography on Q-Sepharose, hydroxapatite, and heparin Sepharose, in each case eluting with a salt gradient. Western blots of the heparin Sepharose fractions were probed with antibodies raised against various mammalian MAPKKKs, including A-Raf, B-Raf, C-Raf, Mos, and MEKK1. Of these five MAPKKKs, we detected appropriately sized bands with B-Raf, C-Raf, and Mos antibodies, and of the three detected, the B-Raf band best correlated with MAPKKK activity, suggesting that B-Raf (or perhaps a subset of the B-Raf molecules, since the correspondence between B-Raf protein levels and MAPKKK activity was not perfect) might be the relevant MAPKKK ( Figure 1b and data not shown).
To test the possibility that the partially purified MAPKKK activity was due to Xenopus B-Raf, pooled heparin Sepharose column fractions were subjected to immunoprecipitation with mammalian B-Raf antibodies. As shown in Figure 1c , MAPKKK activity was quantitatively brought down by B-Raf antibodies, but not by control IgG. Thus, the partially purified MAPKKK activity was either associated with or related to B-Raf. We also subjected cruder MAPKKK-containing fractions from the Q-Sepharose chromatography step to immunoprecipitation with B-Raf and control IgG antibodies. Again, the B-Raf antibody brought down most of the MAPKKK activity, and the control IgG did not (data not shown). Finally, both B-Raf protein and the MAPKKK activity were found to bind quantitatively to a GST-MEK1 affinity column (data not shown). These results demonstrate that a B-Raf-like protein, or conceivably a B-Raf-associated protein, accounted for the MAPKKK activity.
Cloning Xenopus B-Raf We therefore undertook the cloning, expression, and characterization of Xenopus B-Raf. We used Xenopus EST sequence data to design B-Raf-specific PCR primers, and obtained the full-length B-Raf open reading frame by RACE. Overall, the predicted Xenopus B-Raf protein was 82% identical to human B-Raf, and was less similar to human A-Raf (46% identical) and CRaf (47% identical). Over their kinase domains, human and Xenopus B-Raf were 98% identical, and over the epitope from which the human B-Raf antibodies were generated (amino acids 12-156) the two proteins were 95% identical. This high degree of similarity accounts for the apparent recognition of the Xenopus protein by anti-human B-Raf antibodies. Dendrogram analysis showed that the kinase domains of the vertebrate B-Raf proteins are more highly conserved than those of the vertebrate C-Raf and A-Raf proteins, suggesting that there may be more constraints to B-Raf evolution than there are to C-Raf and A-Raf evolution ( Figure 2 ). In addition, the kinase domains of the Caenorhabditis elegans and Drosophila Raf homologs are slightly more similar to those of the vertebrate B-Raf proteins than to A-Raf or C-Raf proteins ( Figure 2 ).
The full-length Xenopus B-Raf cDNA was subcloned into a bacterial expression vector, and the recombinant Figure 2 Dendrogram of kinase domain sequences of A-Raf, B-Raf, and C-Raf proteins. Kinase domains were aligned using Clustal X, and a bootstrapped tree was constructed. Scale bar denotes 10% sequence divergence. (Figure 3b ). By comparison, C-Raf was estimated to be approximately 100 nM (Figure 3c ), and Mos is approximately 10 nM (Yew et al., 1992) . B-Raf therefore appears to be an unusually abundant MEK kinase, and is comparable in abundance to its downstream targets MEK1 (1300 nM) and p42 MAPK (330 nM) (Ferrell, 1996b) .
Incubation of B-Raf with l phosphatase collapsed the B-Raf doublet down to a tighter B97 kDa band ( Figure 3a , lane 3). This finding indicates that the two B-Raf bands represent hyperphosphorylated (upper) and hypophosphorylated (lower) B-Raf protein, rather than two splice variants of B-Raf.
Cdc2/cyclin B does not regulate B-Raf kinase activity
To further explore the interplay between Cdc2/cyclin B and B-Raf, we examined whether the activity of B-Raf is stimulated in D90-cyclin-B-treated egg extracts. As shown in Figure 4b , B-Raf immunoprecipitates from control and D90-cyclin-B-treated egg extracts showed equal activities towards recombinant GST-MEK1. To make sure that the equal activities were not a consequence of saturation of the kinase assay, we assayed the activities of various amounts of B-Raf from control and D90-cyclin B-treated extracts. The amount of activity measured was proportional to the amount of extract from which the B-Raf was precipitated (Figure 4b ), arguing against saturation. In contrast, B-Raf was activated by the addition of active H-Ras-V12 (Figure 4a) .
Next, we examined whether B-Raf changed in activity in cycling Xenopus egg extracts. As shown in Figure 4c , there was no apparent change in B-Raf activity as extracts entered and exited mitosis.
We also examined the activity of B-Raf during progesterone-induced Xenopus oocyte maturation (Figure 4d ), after parthenogenetic activation of Xenopus eggs (Figure 4e) , and during the first few embryonic cell cycles (Figure 4f ). We detected no significant changes in B-Raf activity during any of these processes.
B-Raf is required for oncogenic Ras-stimulated p42 MAPK activation in Xenopus egg extracts Given the lack of evidence for regulation of B-Raf downstream of D90-cyclin B-Cdc2, and our previous study showing that Mos is required for D90-cyclin B-induced p42 MAPK activation but B-Raf is not (Yue and Ferrell, 2004) , we turned our attention to other MAPK-activating stimuli that might be mediated by B-Raf. Activated forms of Ras can bring about p42 MAPK activation in Xenopus oocytes and Xenopus egg extracts (Barrett et al., 1990; Sadler et al., 1990; Hattori et al., 1992; Shibuya et al., 1992; VanRenterghem et al., 1993) , and, as mentioned above, this may be physiologically important for transmitting signals from the classical progesterone receptor through Src to p42 MAPK (Bayaa et al., 2000; Tian et al., 2000; Boonyaratanakornkit et al., 2001) , or from receptor tyrosine kinases to p42 MAPK (Kimelman et al., 1988; Amaya et al., 1991; Park et al., 2004) . We therefore examined whether B-Raf and/or C-Raf (the other Raf family member detectable in Xenopus eggs) were required for Ras-mediated p42 MAPK activation in egg extracts.
We found that the addition of V12 H-Ras to interphase Xenopus egg extracts brought about activation of MEK1 and p42 MAPK (Figure 5a ) as well as B-Raf (Figure 4a ), consistent with previous reports (Shibuya et al., 1992; Shibuya and Ruderman, 1993; VanRenterghem et al., 1993; Fukuda et al., 1994) . Immunodepletion of MEK1 blocked Ras-dependent p42 MAPK activation (Figure 5c ), indicating that MEK1 is required for this process, as expected. MEK1 antibodies also precipitated a substantial fraction of the B-Raf and C-Raf (Figure 5b ), suggesting that MEK1 physically associates with B-Raf and C-Raf in extracts. Depletion of either B-Raf or C-Raf from egg extracts partially inhibited Ras-induced p42 MAPK activation, and codepletion of both B-Raf and C-Raf completely blocked Ras-induced p42 MAPK activation without depleting MEK1 (Figure 5c ). In contrast, depletion of Mos from egg extracts had little effect on Ras-induced p42 MAPK activation (Figure 5c ). These data indicate that both B-Raf and C-Raf contribute to Ras-induced p42 MAPK activation in Xenopus egg extracts, and that Mos is not required.
Discussion
Here, we report the purification and characterization of Xenopus B-Raf from egg extracts. We have shown that B-Raf is an abundant MAPKKK (B450 nM in Interphase extracts were treated with or without D90-cyclin B. B-Raf kinase activity was assessed using GST-MEK1 as substrate. (c) B-Raf kinase activity in cycling extracts. A cycling extract was prepared and warmed to room temperature to initiate cycling. The times indicated are times after warming. B-Raf activity was assessed by immune complex kinase assay with GST-MEK1 as substrate. Cdc2 activity was assessed by histone H1 kinase assay. Assays were quantified by PhosphorImager analysis (Molecular Dynamics). (d) B-Raf activity during oocyte maturation. Stage VI oocytes were stimulated with progesterone (6 mM) and frozen at the times indicated. B-Raf kinase assay using GST-MEK1 as substrate (bottom panel). A p42 MAPK immunoblot (middle panel) and H1 kinase assays (top panel) were also performed. (e) B-Raf activity after egg activation. Eggs were parthenogenetically activated by electric shock and lysed at the indicated time points. B-Raf assays, histone H1 kinase assays, and a p42 MAPK immunoblot were performed as in (a). (f) B-Raf activity during early embryogenesis. Eggs were fertilized in vitro and lysed at the indicated time points. Histone H1 kinase assays and B-Raf kinase assays using GST-MEK1 as substrate were then performed.
concentration, compared to B10 nM for Mos and B100 nM for C-Raf; Figure 3 ), and has a substantial but unchanging activity throughout oocyte maturation and early embryogenesis (Figure 4) . We have also demonstrated that both Cdc2-cyclin B (Figure 1a) and the oncogenic V12 H-Ras protein (Figure 5a ) can activate the p42 MAPK cascade in egg extracts, in agreement with previous reports (Hattori et al., 1992; Shibuya et al., 1992; Itoh et al., 1993; VanRenterghem et al., 1993; Fukuda et al., 1994) . However, Cdc2-cyclin B does not regulate B-Raf kinase activity or its interaction with MEK1 (Figure 4 and data not shown). Immunodepletion of B-Raf, C-Raf, or both from egg extracts does not block the ability of Cdc2-cyclin B to activate the p42 MAPK cascade, whereas depletion of Mos does (Yue and Ferrell, 2004) . In contrast, depletion of B-Raf and C-Raf from extracts inhibits the activation of p42 MAPK by V12-H-Ras, whereas depletion of Mos has no effect ( Figure 5 ). Collectively, our results indicate that B-Raf and C-Raf act as partially redundant mediators of Ras signaling in Xenopus egg extracts, and there is little if any overlap between the signals mediated by the Raf proteins and those mediated by Mos.
Two groups previously reported the fractionation of MAPKKK activities from Xenopus egg extracts. Both groups found that their main MAPKKK activities bound to anion exchange resins and eluted at about the same salt concentration as B-Raf does from QSepharose (Itoh et al., 1993; Matsuda et al., 1993) . This suggests that the Nishida group's MAPKKK activity (Matsuda et al., 1993) and the Takai group's Rasactivated Erk kinase stimulator (REKS) (Itoh et al., 1993) were, in fact, B-Raf. Indeed, the Takai and Weber groups later showed that the main MEK activator protein in bovine brain was B-Raf (Catling et al., 1994; Yamamori et al., 1995) , again consistent with our findings here for Xenopus eggs. The high abundance of B-Raf in Xenopus eggs rationalizes its identification in this system. Perhaps B-Raf is similarly high in abundance in brain.
The mitotic activation of p42 MAPK occurs not only in Xenopus egg extracts, but also at the kinetochores in several mammalian cell lines Zecevic et al., 1998) , and microinjected Mos localizes to kinetochores in PtK1 cells (Wang et al., 1994) . In contrast, immunostaining with a specific anti-B-Raf antibody in HeLa cells shows that B-Raf is located in cytoplasm, with no apparent kinetochore staining (Yue and Ferrell, unpublished results) . Hence, it is possible that endogenous Mos localizes to kinetochores, which could put Mos in the appropriate location to be responsible for the mitotic activation of kinetochoreassociated MEK and ERKs.
Recently, C-Raf was shown to be required for MEK1 activation on the Golgi apparatus in late prophase and to be required for Golgi complex fragmentation in mitosis in mammalian cells (Acharya et al., 1998; Colanzi et al., 2003) . Xenopus egg extracts may provide a good system for assessing the roles of C-Raf and B-Raf in mitotic Golgi regulation.
B-Raf, like other Raf family members, is regulated by multiple mechanisms involving phosphorylation/dephosphorylation, protein-protein interaction, and intracellular translocalization (Chong et al., 2003) . In addition, alternative splicing can modulate the kinase activity and oncogenic properties of B-Raf Eychene et al., 1995; Papin et al., 1998) . In Xenopus egg extracts and oocytes, B-Raf appears to be expressed as a single spliced form, but migrates as two diffuse bands due to the presence of some B-Raf hyperphosphorylation even in unstimulated extracts and oocytes. Along these lines, S445 in B-Raf has been shown to be constitutively phosphorylated, whereas the homologous site in C-Raf is phosphorylated in a Ras-dependent fashion, which may account for the high basal activity of B-Raf compared to C-Raf (Mason et al., 1999) .
In Xenopus oocytes, eggs, and embryos, probably the best established function of Ras is in mesoderm induction (Harland and Gerhart, 1997) . Clearly B-Raf is a plausible candidate for a critical Ras effector in this context. In addition, recent studies implicate EGF receptor ligands in the regulation of mouse oocyte maturation (Park et al., 2004) , although current evidence suggests that the EGF receptor ligands act on cumulus cells, not directly on oocytes. Other studies of the classical progesterone receptor in oocytes have implicated Src in relaying nontranscriptional signals (Boonyaratanakornkit et al., 2001) , raising the possibility that Ras and B-Raf may be relevant to Xenopus oocyte maturation through this mechanism (although we have not detected any changes in B-Raf activity in progesterone-treated oocytes). Moreover, two previous studies have shown that dominant-negative C-Raf proteins interfere with progesterone-induced p42 MAPK activation in Xenopus oocytes (Fabian et al., 1993; Muslin et al., 1993) , again supporting the idea that C-Raf or B-Raf or both proteins are relevant to oocyte maturation. Although the present results underscore the separateness of Mos (which is relevant to D90-cyclininduced p42 MAPK activation) from B-Raf and C-Raf (which are relevant to Ras-induced p42 MAPK activation) in the responses to some stimuli, it seems possible that in a physiological context, all three MAPKKKs contribute to progesterone-induced p42 MAPK activation. It should be interesting to further examine the interplay between Mos, B-Raf, and C-Raf in oocyte maturation.
Materials and methods
Preparation and manipulation of oocytes, eggs, and egg extracts Xenopus eggs were obtained as described (Murray, 1991) . Cycloheximide-treated interphase egg extracts and cycling egg extracts were prepared as described (Murray, 1991; Smythe and Newport, 1991) . To drive interphase extracts into a permanent mitotic state, extracts were incubated with 200 nM nondegradable sea urchin D90-cyclin B for 60 min. Progression into mitosis was monitored by sperm morphology changes, visualized by DAPI staining and fluorescence microscopy, and by histone H1 kinase assay.
Eggs were fertilized in vitro as described (Newport and Kirschner, 1982) . Collagenase-treated Xenopus oocytes were obtained, incubated, and lysed as described previously (Sohaskey and Ferrell, 1999; Bagowski et al., 2001) .
Immunodepletions
Immunodepletion of B-Raf, C-Raf, Mos, or MEK1 was accomplished by incubating extracts for 60 min for two rounds at 41C with anti-B-Raf antibody (SC-9002, Santa Cruz Biotechnology), anti-C-Raf/Raf-1 antibody (SC-133, Santa Cruz Biotechnology), anti-Mos antibody (SC-86, Santa Cruz Biotechnology), or anti-MEK1 antibody (#662, generated in this laboratory) prebound to protein A-Sepharose beads (Sigma). Mock depletions were carried out with rabbit immunoglobulin G (IgG) in place of primary antibody.
In vitro MEK kinase assay An in vitro linked kinase assay using recombinant GST-MEK1 (human) and His 6 -p42 MAPK (Xenopus) as substrates was performed on column fractions. Briefly, 10 ml aliquots of column fractions were added to 10 ml of kinase reaction mixture consisting of 10 mM cAMP-dependent protein kinase inhibitor, 0.75 mM Na 3 VO 4 , 5 mM EGTA, 0.2 mM ATP, 13 mM HEPES-NaOH, pH 7.3, 0.1 mC/ml [g-32 P]ATP, and 64 mM MgCl 2 , and incubated at 301C for 10 min. Next, recombinant GST-MEK1 proteins were added to the reaction and the incubation was continued for 10 min. Recombinant His 6 -Erk2 protein was then added to the reaction. After 10 min, the reaction was stopped by the addition of SDS sample buffer. Proteins were subjected to electrophoresis through 12.5% SDS polyacrylamide gels (acrylamide: bisacrylamide, 29:1), and transferred to an Immobilon P (Millipore) blotting membrane. 32 P labeled GST-MEK1 and His 6 -Erk2 were visualized by autoradiography.
In vitro histone H1, p42 MAPK, or MEK1 kinase assays were performed as described previously (Walter et al., 1997; Sohaskey and Ferrell, 1999 ).
An in vitro B-Raf kinase assay was performed on interphase extracts treated with or without cyclin B, or on cycling egg extracts. Briefly, extracts (5 ml) were diluted in 100 ml EB buffer, and were incubated with anti-B-Raf antibody prebound to protein A-Sepharose beads (Sigma) with rocking for 1 h at 41C. After three washes in EB containing 0.1% Nonidet P-40 and one wash in detergent-free EB, 25 ml of kinase reaction mixture were added containing 100 ng GST-Flag-MEK1. The reaction was stopped, after incubation at 301C for 10 min, with SDS sample buffer, and the proteins were separated on 10% SDS polyacrylamide gels (acrylamide:bisacrylamide, 29:1) and transferred to an Immobilon P (Millipore) blotting membrane.
32
P labeled GST-MEK1 was visualized by autoradiography.
Purification of B-Raf from Xenopus egg extract
All chromatography steps were carried out using a fast protein liquid chromatography (FPLC) station (Pharmacia) at 41C. After incubation with the nondegradable D90-cyclin B (200 nM) for 60 min at room temperature, egg extracts (4 ml) were applied to two HiTrap Q columns in tandem (Amersham) equilibrated with buffer A (10 mM Hepes, 1 mM MgCl 2 , 0.01 mM CaCl 2 , 50 mM Sucrose). The column was washed with 10 column volumes of buffer A and eluted with a linear gradient of 40 ml buffer A to buffer B (buffer A þ 1 M NaCl). Fractions of 1 ml were collected and assayed for MEKK activity as described above. The active factions were pooled, mixed with 15% ammonium sulfate for overnight, and centrifuged at 20 000 g for 15 min at 41C. The resulting pellet was resuspended in 1 ml buffer A and loaded to a 5 ml hydroxyapatite column (Bio-Rad). The hydroxyapatite column was eluted with a linear gradient of 20 ml buffer A to buffer B. Fractions of 1 ml were collected and the active fractions were pooled and applied to 5 ml Heparin column (Amersham) equilibrated with buffer A. The column was then eluted with a linear gradient of 20 ml buffer A to buffer B. The fractions of 0.5 ml were collected and assayed for MEKK activity.
Cloning a Xenopus B-Raf cDNA RNA was typically obtained from 20 frozen Xenopus eggs using RNAeasy kits (Qiagen) according to the manufacturer's instructions. The cDNA pools were then generated from egg total RNA by RT-PCR (Invitrogen) according to the manufacturer's instructions. Five Xenopus B-Raf EST clones were found in Genebank, including one covering the 3 0 end of Xenopus B-Raf. The 5 0 sequence of Xenopus B-Raf was obtained by 5 0 RACE reactions performed as recommended by the manufacturer (Invitrogen). The primers used in 5 GAGGGGGTGTGCAGGGCTGA. Three DNA fragments ranging from 400 to 550 bp were obtained. All three fragments contain the same start codon and some 5 0 UTR. The full length of Xenopus B-Raf was then obtained by PCR from Xenopus egg cDNA pool. The primers used in PCR were: 5 0 primer, CATGCATGCCATGGCGGCGCTAAGTGGGGGATCAG CAGAG; 3 0 primer, CCCCCCAAGCTTTCACAGGGCCCC GATAACAAACCCACCATA. The PCR-amplified fragments were gel-purified and subcloned into pRSET-A (Invitrogen).
Recombinant proteins
His 6 -B-Raf was expressed in bacteria and lysed essentially as described (Wang et al., 1997) . The clarified cell extracts were loaded to a 5 ml nickel-chelated HiTrap column (Amersham) using FPLC station. The column was washed with 10 volumes of wash buffer (50 mM NaH 2 PO 4 , pH 8.0, 300 mM NaCl, 20 mM imidazole), and fusion proteins were eluted with 10 ml elution buffer (50 mM NaH 2 PO 4 , pH 8.0, 300 mM NaCl, 200 mM imidazole).
His 6 -and FLAG-tagged recombinant C-Raf was expressed in insect cells and partially purified on FLAG beads. D90-cyclin B was expressed in bacteria and purified on a 5 ml GSTrap column (Amersham). p42 MAPK was expressed in bacteria and purified on a 5 ml nickel-chelated HiTrap column (Amersham). GST-tagged V12 H-Ras was purchased from Cytoskeleton (Denver, CO, USA) and was loaded with GTP as described (Shibuya et al., 1992) .
Western blot analysis
Aliquots of egg extracts or column fractions were diluted in SDS sample buffer and submitted to electrophoresis on 10 or 12.5% SDS polyacrylamide gels (acrylamide:bisacrylamide, 100:1). Proteins were transferred to an Immobilon P (Millipore, Bedford, MA, USA) blotting membrane, which was then blocked with 3% milk in Tris-buffered saline (20 mM Tris, 150 mM NaCl, pH 7.6), and incubated for 1 h with one of the following primary antibodies: B-Raf (SC-9002, Santa Cruz Biotecnhology), 1:500 dilution; C-Raf/Raf-1 (SC-133, Santa Cruz Biotechnology), 1:500 dilution; MEK1 (662, this laboratory), 1:1000 dilution; or p42 MAPK (DC3, this laboratory), 1:1000 dilution. After washing, the blots were probed with a secondary antibody and bands were detected by chemiluminescence.
Abbreviations ERK, extracellular signal-regulated kinase; FPLC, fast protein liquid chromatography; MEK, MAPK kinase or ERK kinase; MAPK, mitogen-activated protein kinase; MAPKKK, MAP kinase kinase kinase; REKS, Ras-activated ERK kinase stimulator.
